RecruitingNCT07075731

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Sponsor

University of Minnesota

Enrollment

40 participants

Start Date

Jun 30, 2025

Study Type

OBSERVATIONAL

Conditions

Cancer Screening Transgender Gender Diverse Populations

Summary

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how often transgender and gender-diverse people who are seeking or have had a gender-affirming hysterectomy receive appropriate cancer screening for the cervix and uterus, to improve healthcare practices for this community. **You may be eligible if...** - You are 18 years or older - You identify as transgender or gender diverse - You have had a hysterectomy, or are planning to have one - You can speak, read, and understand English - You are able to give voluntary, informed consent **You may NOT be eligible if...** - You are under 18 years old - You have opted out of research - You are unable to give informed consent - You are a member of the study's community advisory board Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.